Updates from The Motley Fool

Latest updates on Transition Therapeutics Inc. from Fool.com.


Stock Performance

TTHI vs. S&P 500 | 2 Year Performance
TTHI 1-Day Stock Chart
TTHI 5-Day Stock Chart
TTHI 1-Month Stock Chart
TTHI 3-Month Stock Chart
TTHI 6-Month Stock Chart
TTHI 1-Year Stock Chart
TTHI 2-Year Stock Chart
TTHI 5-Year Stock Chart
View Interactive TTHI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Transition Therapeutics Inc..
Current Price: $0.80
Prev Close: $0.80
Open: $0.80
Bid: $0.66
Ask: $0.00
Day's Range: $0.75 - $0.80
52wk Range: $0.70 - $9.30
Volume: 9,585
Avg Vol 84,345
Market Cap: $31.10M
P/E (ttm): -0.75
EPS (ttm): -$1.07
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Transition Therapeutics Inc..
CAPS Rating 3 out of 5
 
54 Outperform
14 Underperform
CAPS All Stars
 
10 Outperform
7 Underperform

How do you think Transition Therapeutics Inc. will perform against the market?



You pick for Transition Therapeutics Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Transition Therapeutics Inc..

Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers